ICAM1 and head and neck squamous cell carcinoma: In the present study, we demonstrate a potentially previously unreported mechanism by which IL-1β induces ICAM1 expression via modulation of intracellular ROS levels through SOD2 activation and CAT inhibition in HNSCC.